SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Protein Design Labs (PDLI): Stock strong
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
407 58 0 PDLI
Emcee:  Stanley Cowen Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
232ICOS to Manufacture Clinical Candidate for Protein Design Labs BOTHELL, Wash.--nigel bates-10/9/2003
231ARIUS Research and Protein Design Labs, Inc. Sign Agreement For Expanded Collabonigel bates-10/2/2003
230Protein Design Labs and Genentech Extend Patent Licensing Master Agreement Fridanigel bates-9/19/2003
229A Battle in Biotech The Motley Fool Take Protein Design Labs Genentech Biotemopgcw-8/15/2003
228Protein Design Labs Reports on Status of Genentech Humanization Patent License Anigel bates-8/15/2003
227DNA looking to shaft PDLI on license revenue for Avastin? Or just a negotiatingtuck-7/21/2003
226Protein Design Labs Begins Trial of Anti-a5B1 Integrin Antibody in Solid Tumors nigel bates-6/2/2003
225Protein Design Labs Reports Progress with Three Humanized Antibodies in Inflammanigel bates-5/19/2003
224Protein Design Labs Says It Has Stopped Development of Anti-IL-4 Antibody Follownigel bates-5/8/2003
223Protein Design Labs Names Glen Y. Sato Chief Financial Officer FREMONT, Calif.,nigel bates-5/6/2003
222>>FREMONT, Calif., April 29 /PRNewswire-FirstCall/ -- Protein Design Labs,tuck-4/29/2003
221Parking from the 10K Antibody Product Indication(s) Status Zenapax (daclizumab)nigel bates-3/31/2003
220FREMONT, Calif. and ALEXANDRIA, Va., March 18 /PRNewswire-FirstCall/ -- Protein nigel bates-3/18/2003
219FREMONT, Calif., Feb. 26 /PRNewswire-FirstCall/ -- Protein Design Labs, Inc. (PDnigel bates-2/26/2003
218>>SOUTH SAN FRANCISCO, Calif., Feb. 25 /PRNewswire-FirstCall/ -- Exelixis,tuck-2/25/2003
217Thanks. Parking - TORONTO, Feb. 6 /CNW/ - ARIUS Research Inc. (TSX Venture: YAnigel bates-2/6/2003
216It has something to do with the place marker. If the original application is WOscaram(o)uche-2/5/2003
215Just nooding around looking at the Eos US patents. Issued: <i>6,516,276 Mnigel bates-2/5/2003
214Protein Design Labs Announces Agreement With MedImmune for Humanized Antibody Panigel bates-1/6/2003
213TORONTO, Oct. 8 /CNW/ - ARIUS Research Inc. (TSX-VE: YAR) today said that it hasnigel bates-10/9/2002
212Protein Design Labs Begins Phase I Clinical Trial of Nuvion(R) in Ulcerative Colnigel bates-7/9/2002
211Protein Design Labs Begins Phase I Clinical Trial Of SMART(R) Anti-IL-12 Antibodnigel bates-6/26/2002
210The stock was overvalued by insider trading. Board members sold their shares lasEdgar Wien-5/25/2002
209PDLI takes a swing at another indication, but placebo throws a curve . . . &tuck-5/22/2002
208hmmmmmm.......... Blood 1990 Jun 15;75(12):2375-87 Identification and charactscaram(o)uche-5/14/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News